Page 5 - Atxs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Atxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Atxs Today - Breaking & Trending Today
Opaleye Management Inc. increased its stake in shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) by 96.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 261,703 shares of the biotechnology company’s stock after acquiring an additional 128,203 shares during the quarter. […] ....
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totalling 573,400 shares, a decrease of 16.1% from the March 31st total of 683,300 shares. Based on an average daily trading volume, of 224,800 shares, the days-to-cover ratio […] ....
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) shares crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $12.24 and traded as low as $11.35. Astria Therapeutics shares last traded at $11.73, with a volume of 94,585 shares changing hands. Analysts Set New Price […] ....
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) shares crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $12.24 and traded as low as $11.35. Astria Therapeutics shares last traded at $11.73, with a volume of 94,585 shares changing hands. Analysts Set New Price […] ....
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) – Equities research analysts at Oppenheimer issued their Q1 2023 earnings per share estimates for Astria Therapeutics in a research note issued on Wednesday, March 29th. Oppenheimer analyst H. Singh forecasts that the biotechnology company will post earnings of ($0.46) per share for the quarter. The consensus estimate […] ....